Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Iradimed (IRMD) FCF Payout Ratio (2022 - 2025)

Historic FCF Payout Ratio for Iradimed (IRMD) over the last 4 years, with Q3 2025 value amounting to 0.37.

  • Iradimed's FCF Payout Ratio rose 323.09% to 0.37 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.57, marking a year-over-year decrease of 1404.02%. This contributed to the annual value of 0.78 for FY2024, which is 6463.23% down from last year.
  • Per Iradimed's latest filing, its FCF Payout Ratio stood at 0.37 for Q3 2025, which was up 323.09% from 0.42 recorded in Q2 2025.
  • Iradimed's FCF Payout Ratio's 5-year high stood at 10.6 during Q1 2022, with a 5-year trough of 7.56 in Q1 2023.
  • In the last 4 years, Iradimed's FCF Payout Ratio had a median value of 0.42 in 2025 and averaged 1.22.
  • Its FCF Payout Ratio has fluctuated over the past 5 years, first crashed by 17129.04% in 2023, then surged by 12921.71% in 2024.
  • Quarter analysis of 4 years shows Iradimed's FCF Payout Ratio stood at 10.6 in 2022, then plummeted by 171.29% to 7.56 in 2023, then surged by 107.87% to 0.59 in 2024, then plummeted by 37.83% to 0.37 in 2025.
  • Its last three reported values are 0.37 in Q3 2025, 0.42 for Q2 2025, and 3.64 during Q1 2025.